Structural Basis for Mouse Receptor Recognition by SARS-CoV-2 Omicron Variant

Overview

Journal Proc Natl Acad Sci U S A

Specialty Science

Date 2022 Oct 18

PMID 36256797

Authors

Wei Zhang

Ke Shi

Qibin Geng

Gang Ye

Hideki Aihara

Fang Li

Affiliations

Soon will be listed here.

Abstract

The sudden emergence and rapid spread of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) omicron variant has raised questions about its animal reservoir. Here, we investigated receptor recognition of the omicron's receptor-binding domain (RBD), focusing on four of its mutations (Q493R, Q498R, N501Y, and Y505H) surrounding two mutational hotspots. These mutations have variable effects on the RBD's affinity for human angiotensin-converting enzyme 2 (ACE2), but they all enhance the RBD's affinity for mouse ACE2. We further determined the crystal structure of omicron RBD complexed with mouse ACE2. The structure showed that all four mutations are viral adaptations to mouse ACE2: three of them (Q493R, Q498R, and Y505H) are uniquely adapted to mouse ACE2, whereas the other one (N501Y) is adapted to both human ACE2 and mouse ACE2. These data reveal that the omicron RBD was well adapted to mouse ACE2 before omicron started to infect humans, providing insight into the potential evolutionary origin of the omicron variant.

Citing Articles

Research progress of spike protein mutation of SARS-CoV-2 mutant strain and antibody development.

Huan X, Zhan J, Gao H Front Immunol. 2024; 15:1407149.

PMID: 39624100 PMC: 11609190. DOI: 10.3389/fimmu.2024.1407149.

The effects of iron deficient and high iron diets on SARS-CoV-2 lung infection and disease.

Carolin A, Frazer D, Yan K, Bishop C, Tang B, Nguyen W Front Microbiol. 2024; 15:1441495.

PMID: 39296289 PMC: 11408339. DOI: 10.3389/fmicb.2024.1441495.

Sulforaphane's Nuclear Factor Erythroid 2-Related Factor 2 (Nrf2)-Dependent and -Independent Mechanism of Anti-SARS-CoV-2 Activity.

Yan Z, Liang W, Zhu L, Kreso I, Romero V, Smith M J Respir Biol Transl Med. 2024; 1(3).

PMID: 39220635 PMC: 11360660. DOI: 10.35534/jrbtm.2024.10010.

Structural basis for mouse receptor recognition by bat SARS2-like coronaviruses.

Zhang W, Shi K, Hsueh F, Mendoza A, Ye G, Huang L Proc Natl Acad Sci U S A. 2024; 121(32):e2322600121.

PMID: 39083418 PMC: 11317568. DOI: 10.1073/pnas.2322600121.

Therapeutic nanobodies against SARS-CoV-2 and other pathogenic human coronaviruses.

Yang Y, Li F, Du L J Nanobiotechnology. 2024; 22(1):304.

PMID: 38822339 PMC: 11140877. DOI: 10.1186/s12951-024-02573-7.

References

Huang K, Zhang Y, Hui X, Zhao Y, Gong W, Wang T . Q493K and Q498H substitutions in Spike promote adaptation of SARS-CoV-2 in mice. EBioMedicine. 2021; 67:103381. PMC: 8118724. DOI: 10.1016/j.ebiom.2021.103381. View

Leist S, Dinnon 3rd K, Schafer A, Tse L, Okuda K, Hou Y . A Mouse-Adapted SARS-CoV-2 Induces Acute Lung Injury and Mortality in Standard Laboratory Mice. Cell. 2020; 183(4):1070-1085.e12. PMC: 7510428. DOI: 10.1016/j.cell.2020.09.050. View

Wu K, Chen L, Peng G, Zhou W, Pennell C, Mansky L . A virus-binding hot spot on human angiotensin-converting enzyme 2 is critical for binding of two different coronaviruses. J Virol. 2011; 85(11):5331-7. PMC: 3094985. DOI: 10.1128/JVI.02274-10. View

Virtanen J, Aaltonen K, Kegler K, Venkat V, Niamsap T, Kareinen L . Experimental Infection of Mink with SARS-COV-2 Omicron Variant and Subsequent Clinical Disease. Emerg Infect Dis. 2022; 28(6):1286-1288. PMC: 9155874. DOI: 10.3201/eid2806.220328. View

Gu H, Krishnan P, Ng D, Chang L, Liu G, Cheng S . Probable Transmission of SARS-CoV-2 Omicron Variant in Quarantine Hotel, Hong Kong, China, November 2021. Emerg Infect Dis. 2021; 28(2):460-462. PMC: 8798678. DOI: 10.3201/eid2802.212422. View

Liao S, Du Q, Meng J, Pang Z, Huang R . The multiple roles of histidine in protein interactions. Chem Cent J. 2013; 7(1):44. PMC: 3599372. DOI: 10.1186/1752-153X-7-44. View

Emsley P, Cowtan K . Coot: model-building tools for molecular graphics. Acta Crystallogr D Biol Crystallogr. 2004; 60(Pt 12 Pt 1):2126-32. DOI: 10.1107/S0907444904019158. View

Li W, Wong S, Li F, Kuhn J, Huang I, Choe H . Animal origins of the severe acute respiratory syndrome coronavirus: insight from ACE2-S-protein interactions. J Virol. 2006; 80(9):4211-9. PMC: 1472041. DOI: 10.1128/JVI.80.9.4211-4219.2006. View

Gawish R, Starkl P, Pimenov L, Hladik A, Lakovits K, Oberndorfer F . ACE2 is the critical in vivo receptor for SARS-CoV-2 in a novel COVID-19 mouse model with TNF- and IFNγ-driven immunopathology. Elife. 2022; 11. PMC: 8776253. DOI: 10.7554/eLife.74623. View

10.

Sun S, Gu H, Cao L, Chen Q, Ye Q, Yang G . Characterization and structural basis of a lethal mouse-adapted SARS-CoV-2. Nat Commun. 2021; 12(1):5654. PMC: 8476561. DOI: 10.1038/s41467-021-25903-x. View

11.

Zhou P, Yang X, Wang X, Hu B, Zhang L, Zhang W . A pneumonia outbreak associated with a new coronavirus of probable bat origin. Nature. 2020; 579(7798):270-273. PMC: 7095418. DOI: 10.1038/s41586-020-2012-7. View

12.

Mallapaty S . Where did Omicron come from? Three key theories. Nature. 2022; 602(7895):26-28. DOI: 10.1038/d41586-022-00215-2. View

13.

Winn M, Ballard C, Cowtan K, Dodson E, Emsley P, Evans P . Overview of the CCP4 suite and current developments. Acta Crystallogr D Biol Crystallogr. 2011; 67(Pt 4):235-42. PMC: 3069738. DOI: 10.1107/S0907444910045749. View

14.

Zahradnik J, Marciano S, Shemesh M, Zoler E, Harari D, Chiaravalli J . SARS-CoV-2 variant prediction and antiviral drug design are enabled by RBD in vitro evolution. Nat Microbiol. 2021; 6(9):1188-1198. DOI: 10.1038/s41564-021-00954-4. View

15.

Zakhartchouk A, Sharon C, Satkunarajah M, Auperin T, Viswanathan S, Mutwiri G . Immunogenicity of a receptor-binding domain of SARS coronavirus spike protein in mice: implications for a subunit vaccine. Vaccine. 2006; 25(1):136-43. PMC: 7115608. DOI: 10.1016/j.vaccine.2006.06.084. View

16.

Zhang L, Cui Z, Li Q, Wang B, Yu Y, Wu J . Ten emerging SARS-CoV-2 spike variants exhibit variable infectivity, animal tropism, and antibody neutralization. Commun Biol. 2021; 4(1):1196. PMC: 8514557. DOI: 10.1038/s42003-021-02728-4. View

17.

Harvey W, Carabelli A, Jackson B, Gupta R, Thomson E, Harrison E . SARS-CoV-2 variants, spike mutations and immune escape. Nat Rev Microbiol. 2021; 19(7):409-424. PMC: 8167834. DOI: 10.1038/s41579-021-00573-0. View

18.

Wong L, Zheng J, Wilhelmsen K, Li K, Ortiz M, Schnicker N . Eicosanoid signalling blockade protects middle-aged mice from severe COVID-19. Nature. 2022; 605(7908):146-151. PMC: 9783543. DOI: 10.1038/s41586-022-04630-3. View

19.

Li F . Structural analysis of major species barriers between humans and palm civets for severe acute respiratory syndrome coronavirus infections. J Virol. 2008; 82(14):6984-91. PMC: 2446986. DOI: 10.1128/JVI.00442-08. View

20.

Li F . Structure, Function, and Evolution of Coronavirus Spike Proteins. Annu Rev Virol. 2016; 3(1):237-261. PMC: 5457962. DOI: 10.1146/annurev-virology-110615-042301. View